Abstract:The tumor suppressor PTEN plays a critical role in the regulation of multiple cellular processes that include survival, cell cycle, proliferation and apoptosis. PTEN is frequently mutated or deleted in various human cancer cells to promote tumorigenesis. PTEN is regulated by SUMOylation, but the SUMO E3 ligase involved in the SUMOylation of PTEN remains unclear. Here, we demonstrated that PIASxα is a SUMO E3 ligase for PTEN. PIASxα physically interacted with PTEN both in vitro and in vivo. Their interaction depended on the integrity of Phosphatase and C2 domains of PTEN, and the region of PIASxα comprising residues 134-347. PIASxα enhanced PTEN protein stability by reducing PTEN ubiquitination, while the mutation of PTEN SUMO1 conjugation sites neutralized the effect of PIASxα on PTEN protein half-life. Functionally, PIASxα, as a potential tumor suppressor, negatively regulated the PI3K-Akt pathway through stabilizing PTEN protein. Overexpression of PIASxα led to G0/G1 cell cycle arrest, thus triggered cell proliferation inhibition and tumor suppression, whereas PIASxα knockdown or deficiency in catalytic activity abolished the inhibition. Together, our studies suggest that PIASxα is a novel SUMO E3 ligase for PTEN and it positively regulates PTEN protein level in tumor suppression. PTEN (phosphatase and tensin homologue deleted on chromosome TEN) (1) is a well-defined tumor suppressor that plays a critical role in multiple cellular processes, such as cell proliferation, apoptosis, cell cycle arrest and genomic stability maintenance (2-7). PTEN is reduced in expression, deleted or mutated with high frequency in various types of human cancers and is considered to function as a tumor suppressor (8, 9). The classic function of PTEN is to inhibit the PI3K (phosphatidylinositol http://www.jbc.org/cgi/doi/10.1074/jbc.M113.508515 The latest version is at JBC Papers in Press. Published on December 16, 2013 as Manuscript M113.508515 Copyright 2013 by The American Society for Biochemistry and Molecular Biology, Inc. by gest on O cber 0, 2017 hp://w w w .jb.org/ D ow nladed from

SUMOylation of AMPKα1 by PIAS4 specifically regulates mTORC1 signalling

Data from Akt SUMOylation Regulates Cell Proliferation and Tumorigenesis

SUMOylation Activates Large Tumour Suppressor 1 to Maintain the Tissue Homeostasis During Hippo Signalling

Cross-talk between Sirtuin and Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling in the Regulation of S6 Kinase 1 (S6K1) Phosphorylation

AMPK Induces PIAS3 Mediated SUMOylation of E3 Ubiquitin Ligase Smurf1 Impairing Osteogenic Differentiation and Traumatic Heterotopic Ossification

Deubiquitination and Activation of AMPK by USP10.

PIASxα Ligase Enhances SUMO1 Modification of PTEN Protein as a SUMO E3 Ligase

mTORC1 directly inhibits AMPK to promote cell proliferation under nutrient stress

SUMOylation of Large Tumor Suppressor 1 at Lys751 Attenuates Its Kinase Activity and Tumor-Suppressor Functions

Hepatic amino acid-dependent signaling is under the control of AMP-dependent protein kinase

Neuronal Activity-Induced SUMOylation of Akt1 by PIAS3 is Required for Long-Term Potentiation of Synaptic Transmission.

PIASx α enhances SUMO 1 modification of PTEN as a SUMO E 3 ligase

The mixed blessing of AMPK signaling in Cancer treatments

Quantitative SUMO proteomics identifies PIAS1 substrates involved in cell migration and motility

Dynamic modelling of the PI3K/MTOR signalling network uncovers biphasic dependence of mTORC1 activity on the mTORC2 subunit SIN1

SIN1/MIP1 Maintains Rictor-Mtor Complex Integrity and Regulates Akt Phosphorylation and Substrate Specificity

Regulation of Smad4 Sumoylation and Transforming Growth Factor-β Signaling by Protein Inhibitor of Activated STAT1

Unexpected roles for AMPK in the suppression of autophagy and the reactivation of mTORC1 signaling during prolonged amino acid deprivation

PRKAA/AMPK phosphorylation switches the role of RASAL2 from a suppressor to an activator of autophagy

Knockdown of AMPKα2 Promotes Pulmonary Arterial Smooth Muscle Cells Proliferation via mTOR/Skp2/p27Kip1 Signaling Pathway